DTCCX
Price
$15.46
Change
+$0.09 (+0.59%)
Updated
Aug 6 closing price
Net Assets
491.32M
VFFSX
Price
$310.68
Change
+$2.25 (+0.73%)
Updated
Aug 6 closing price
Net Assets
1.49T
Interact to see
Advertisement

DTCCX vs VFFSX

Header iconDTCCX vs VFFSX Comparison
Open Charts DTCCX vs VFFSXBanner chart's image
BNY Mellon Sust US Equity C
Price$15.46
Change+$0.09 (+0.59%)
VolumeN/A
Net Assets491.32M
Vanguard 500 Index Institutional Select
Price$310.68
Change+$2.25 (+0.73%)
VolumeN/A
Net Assets1.49T
DTCCX vs VFFSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DTCCX vs. VFFSX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCCX is a Buy and VFFSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.49T vs. DTCCX (491M). VFFSX pays higher dividends than DTCCX: VFFSX (1.20) vs DTCCX (0.00). DTCCX was incepted earlier than VFFSX: DTCCX (26 years) vs VFFSX (9 years). DTCCX (1.87) is less costly to investors than VFFSX (0.01). DTCCX is a more actively managed with annual turnover of: 30.51 vs. VFFSX (2.00). DTCCX has a lower initial minimum investment than VFFSX: DTCCX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 20.30 vs. DTCCX (11.45). VFFSX return over 5 years is better than : 88.16 vs. DTCCX (26.30).
DTCCXVFFSXDTCCX / VFFSX
Total Expense Ratio1.700.0117,000%
Annual Report Gross Expense Ratio1.870.0118,700%
Fund Existence26 years9 years-
Gain YTD7.7847.211108%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets491M1.49T0%
Annual Yield % from dividends0.001.20-
Returns for 1 year11.4520.3056%
Returns for 3 years13.5052.1326%
Returns for 5 years26.3088.1630%
Returns for 10 years24.65N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.470.06
+1.76%
Arbutus Biopharma Corp
CUK26.780.01
+0.04%
Carnival PLC
SOL1.86N/A
N/A
Emeren Group Ltd
HOOK0.90-0.02
-1.86%
HOOKIPA Pharma Inc.
KYMR41.35-1.62
-3.77%
Kymera Therapeutics